Catherine L Keaty

Title: The Innovations of Catherine L. Keaty

Introduction

Catherine L. Keaty is an accomplished inventor based in Alexandria, VA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic inhibitors. Her work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Catherine L. Keaty holds a patent for "Polynucleotides encoding therapeutic inhibitors of PAI-1." This invention relates to mammalian PAI-1 ligands and modulators. Specifically, it encompasses polypeptides, polypeptide compositions, and polynucleotides that encode polypeptides that act as ligands and/or modulators of PAI-1. The invention also includes polyligands that can be homopolyligands or heteropolyligands, which modulate PAI-1 activity. Furthermore, it addresses ligands and polyligands localized to specific regions of a cell, as well as localization tethers and promoter sequences for spatial control of PAI-1 ligands and polyligands. Additionally, the invention discusses inducible gene switches for temporal control of these ligands and polyligands. Importantly, it outlines methods for treating or preventing atherosclerosis and fibrosis.

Career Highlights

Catherine is currently associated with Intrexon Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on therapeutic applications in medicine.

Collaborations

Catherine has collaborated with notable colleagues, including Thomas David Reed and Charles E. Reed. These partnerships have contributed to the development and refinement of her innovative ideas.

Conclusion

Catherine L. Keaty's contributions to biotechnology and her innovative patent on therapeutic inhibitors of PAI-1 highlight her role as a leading inventor in her field. Her work promises to advance medical treatments and improve patient outcomes.